GORE® Viabahn® Endoprosthesis

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instance_of gptkb:hospital
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:Gore_Endovascular
gptkb:Gore_Interventional_Devices
gptkbp:availability widely available in hospitals
gptkbp:available_sizes various lengths available
gptkbp:clinical_trial endovascular procedures
multiple studies conducted
treatment of stenosis
various phases of trials conducted
widely used in clinical practice
gptkbp:coat_of_arms hydrophilic coating
gptkbp:competitors competes with other vascular devices
gptkbp:complications risk of thrombosis
not suitable for all vascular conditions
potential risks discussed with patients
gptkbp:contraindication not suitable for all patients
gptkbp:design stent graft
gptkbp:diameter various diameters available
gptkbp:education patients should be informed about risks
gptkbp:effective_date FDA approved
gptkbp:events long-term follow-up recommended
regular monitoring required
gptkbp:features flexible design
gptkbp:feedback high satisfaction rates reported
positive reviews from clinicians
gptkbp:first_introduced gptkb:1997
gptkbp:future_plans future studies planned to assess long-term effects
gptkbp:has_experience_in surgeon skill impacts success
https://www.w3.org/2000/01/rdf-schema#label GORE® Viabahn® Endoprosthesis
gptkbp:innovation continuous improvements made
gptkbp:invention patented technology
gptkbp:is_compared_to compared to other stent grafts
gptkbp:is_effective_against demonstrated efficacy in studies
gptkbp:is_monitored_by requires follow-up imaging
gptkbp:is_used_for vascular interventions
gptkbp:manufacturer gptkb:W._L._Gore_&_Associates
gptkbp:market monitored for long-term safety
gptkbp:marketed_as Viabahn® stent graft
gptkbp:material e PTFE
gptkbp:population adults with vascular issues
gptkbp:price varies by region and provider
gptkbp:provides_information_on recommended for specific conditions
included in vascular surgery guidelines
gptkbp:recruitment careful selection improves outcomes
gptkbp:regulatory_compliance CE marked in Europe
gptkbp:research ongoing research into effectiveness
gptkbp:risk_factor age and comorbidities affect outcomes
gptkbp:safety_features generally safe when used correctly
gptkbp:shipping_options percutaneous
gptkbp:specialties specific techniques recommended for use
gptkbp:training training for proper use recommended
gptkbp:treatment gptkb:peripheral_artery_disease
improved blood flow
generally favorable outcomes reported